Texas · 89th Legislature (2025) · Bill

HB 4586: Relating to prohibited direct-to-consumer pharmaceutical advertising; providing an administrative penalty.

In committee Last action April 3, 2025: Referred to Public Health

Plain-language summary

HB 4586 is a bill introduced in the Texas House on March 12, 2025. According to its official title, it concerns: Relating to prohibited direct-to-consumer pharmaceutical advertising; providing an administrative penalty. Primary sponsor: James Frank (Republican). Most recent recorded action (April 3, 2025): Referred to Public Health.

Sponsors

Primary sponsor: James Frank (Republican).